Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 140

1.

Long-term follow-up of an age-adapted C5R protocol followed by radiotherapy in 99 newly diagnosed primary CNS lymphomas: a prospective multicentric phase II study of the Groupe d'Etude des Lymphomes de l'Adulte (GELA).

Ghesquières H, Ferlay C, Sebban C, Perol D, Bosly A, Casasnovas O, Reman O, Coiffier B, Tilly H, Morel P, Van den Neste E, Colin P, Haioun C, Biron P, Blay JY.

Ann Oncol. 2010 Apr;21(4):842-50. doi: 10.1093/annonc/mdp529. Epub 2009 Nov 13.

PMID:
19914958
[PubMed - indexed for MEDLINE]
Free Article
2.

[Therapeutic management of central nervous system lymphomas in a single hematological institute].

Iványi JL, Marton E, Plander M, Gyánó G, Czumbil L, Tóth C.

Orv Hetil. 2009 Oct 18;150(42):1937-44. doi: 10.1556/OH.2009.28703. Hungarian.

PMID:
19812012
[PubMed - indexed for MEDLINE]
3.

Primary non-Hodgkin's lymphoma of the CNS treated with CHOD/BVAM or BVAM chemotherapy before radiotherapy: long-term survival and prognostic factors.

Bessell EM, Graus F, Lopez-Guillermo A, Lewis SA, Villa S, Verger E, Petit J.

Int J Radiat Oncol Biol Phys. 2004 Jun 1;59(2):501-8.

PMID:
15145169
[PubMed - indexed for MEDLINE]
4.

CHOD/BVAM regimen plus radiotherapy in patients with primary CNS non-Hodgkin's lymphoma.

Bessell EM, Graus F, López-Guillermo A, Villá S, Verger E, Petit J, Holland I, Byrne P.

Int J Radiat Oncol Biol Phys. 2001 Jun 1;50(2):457-64.

PMID:
11380234
[PubMed - indexed for MEDLINE]
5.

The C5R protocol: a regimen of high-dose chemotherapy and radiotherapy in primary cerebral non-Hodgkin's lymphoma of patients with no known cause of immunosuppression.

Blay JY, Bouhour D, Carrie C, Bouffet E, Brunat-Mentigny M, Philip T, Biron P.

Blood. 1995 Oct 15;86(8):2922-9.

PMID:
7579384
[PubMed - indexed for MEDLINE]
Free Article
6.

CHOD/BVAM chemotherapy and whole-brain radiotherapy for newly diagnosed primary central nervous system lymphoma.

Laack NN, O'Neill BP, Ballman KV, O'Fallon JR, Carrero XW, Kurtin PJ, Scheithauer BW, Brown PD, Habermann TM, Colgan JP, Gilbert MR, Hawkins RB, Morton RF, Windschitl HE, Fitch TR, Pajon ER Jr; North Central Cancer Treatment Group and Mayo Clinic.

Int J Radiat Oncol Biol Phys. 2011 Oct 1;81(2):476-82. doi: 10.1016/j.ijrobp.2010.06.002. Epub 2010 Aug 26.

PMID:
20800387
[PubMed - indexed for MEDLINE]
7.

Importance of radiotherapy in the outcome of patients with primary CNS lymphoma: an analysis of the CHOD/BVAM regimen followed by two different radiotherapy treatments.

Bessell EM, López-Guillermo A, Villá S, Verger E, Nomdedeu B, Petit J, Byrne P, Montserrat E, Graus F.

J Clin Oncol. 2002 Jan 1;20(1):231-6.

PMID:
11773174
[PubMed - indexed for MEDLINE]
Free Article
8.

Results of treatment of 112 cases of primary CNS lymphoma.

Yamanaka R, Morii K, Shinbo Y, Homma J, Sano M, Tsuchiya N, Yajima N, Tamura T, Hondoh H, Takahashi H, Kakuma T, Tanaka R.

Jpn J Clin Oncol. 2008 May;38(5):373-80. doi: 10.1093/jjco/hyn027. Epub 2008 Apr 15.

PMID:
18413337
[PubMed - indexed for MEDLINE]
Free Article
9.

Chemotherapy alone as initial treatment for primary CNS lymphoma in patients older than 60 years: a multicenter phase II study (26952) of the European Organization for Research and Treatment of Cancer Brain Tumor Group.

Hoang-Xuan K, Taillandier L, Chinot O, Soubeyran P, Bogdhan U, Hildebrand J, Frenay M, De Beule N, Delattre JY, Baron B; European Organization for Research and Treatment of Cancer Brain Tumor Group.

J Clin Oncol. 2003 Jul 15;21(14):2726-31.

PMID:
12860951
[PubMed - indexed for MEDLINE]
Free Article
10.

Salvage therapy and late neurotoxicity in patients with recurrent primary CNS lymphoma treated with a modified ProMACE-MOPP hybrid regimen.

Yamanaka R, Shinbo Y, Sano M, Homma J, Tsuchiya N, Yajima N, Tamura T, Hondoh H, Takahashi H, Morii K, Onda K, Tanaka R.

Leuk Lymphoma. 2007 Jun;48(6):1119-26.

PMID:
17577775
[PubMed - indexed for MEDLINE]
11.

European Organization for Research and Treatment of Cancer and Groupe d'Etude des Lymphomes de l'Adulte very favorable and favorable, lymphocyte-predominant Hodgkin disease.

Wilder RB, Schlembach PJ, Jones D, Chronowski GM, Ha CS, Younes A, Hagemeister FB, Barista I, Cabanillas F, Cox JD.

Cancer. 2002 Mar 15;94(6):1731-8.

PMID:
11920535
[PubMed - indexed for MEDLINE]
Free Article
12.

Combined immunochemotherapy with reduced whole-brain radiotherapy for newly diagnosed primary CNS lymphoma.

Shah GD, Yahalom J, Correa DD, Lai RK, Raizer JJ, Schiff D, LaRocca R, Grant B, DeAngelis LM, Abrey LE.

J Clin Oncol. 2007 Oct 20;25(30):4730-5. Erratum in: J Clin Oncol. 2008 Jan 10;26(2):340.

PMID:
17947720
[PubMed - indexed for MEDLINE]
Free Article
13.

Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin's lymphoma: updated results of the prospective study LNH87-2. Groupe d'Etude des Lymphomes de l'Adulte.

Haioun C, Lepage E, Gisselbrecht C, Bastion Y, Coiffier B, Brice P, Bosly A, Dupriez B, Nouvel C, Tilly H, Lederlin P, Biron P, Brière J, Gaulard P, Reyes F.

J Clin Oncol. 1997 Mar;15(3):1131-7.

PMID:
9060555
[PubMed - indexed for MEDLINE]
Free Article
14.

Primary central nervous system lymphoma: results of a pilot and phase II study of systemic and intraventricular chemotherapy with deferred radiotherapy.

Pels H, Schmidt-Wolf IG, Glasmacher A, Schulz H, Engert A, Diehl V, Zellner A, Schackert G, Reichmann H, Kroschinsky F, Vogt-Schaden M, Egerer G, Bode U, Schaller C, Deckert M, Fimmers R, Helmstaedter C, Atasoy A, Klockgether T, Schlegel U.

J Clin Oncol. 2003 Dec 15;21(24):4489-95. Epub 2003 Nov 3.

PMID:
14597744
[PubMed - indexed for MEDLINE]
Free Article
15.

Salvage treatment with etoposide (VP-16), ifosfamide and cytarabine (Ara-C) for patients with recurrent primary central nervous system lymphoma.

Arellano-Rodrigo E, López-Guillermo A, Bessell EM, Nomdedeu B, Montserrat E, Graus F.

Eur J Haematol. 2003 Apr;70(4):219-24.

PMID:
12656744
[PubMed - indexed for MEDLINE]
16.

Survival benefit of high-dose therapy in poor-risk aggressive non-Hodgkin's lymphoma: final analysis of the prospective LNH87-2 protocol--a groupe d'Etude des lymphomes de l'Adulte study.

Haioun C, Lepage E, Gisselbrecht C, Salles G, Coiffier B, Brice P, Bosly A, Morel P, Nouvel C, Tilly H, Lederlin P, Sebban C, Brière J, Gaulard P, Reyes F.

J Clin Oncol. 2000 Aug;18(16):3025-30.

PMID:
10944137
[PubMed - indexed for MEDLINE]
Free Article
17.

Short intensive primary chemotherapy and radiotherapy in sporadic primary CNS lymphoma (PCL).

Brada M, Hjiyiannakis D, Hines F, Traish D, Ashley S.

Int J Radiat Oncol Biol Phys. 1998 Mar 15;40(5):1157-62.

PMID:
9539572
[PubMed - indexed for MEDLINE]
18.

Systemic chemotherapy alone for patients with non-acquired immunodeficiency syndrome-related central nervous system lymphoma: a pilot study of the BOMES protocol.

Cheng AL, Yeh KH, Uen WC, Hung RL, Liu MY, Wang CH.

Cancer. 1998 May 15;82(10):1946-51.

PMID:
9587129
[PubMed - indexed for MEDLINE]
19.

High-dose chemotherapy with autologous stem-cell transplantation and hyperfractionated radiotherapy as first-line treatment of primary CNS lymphoma.

Illerhaus G, Marks R, Ihorst G, Guttenberger R, Ostertag C, Derigs G, Frickhofen N, Feuerhake F, Volk B, Finke J.

J Clin Oncol. 2006 Aug 20;24(24):3865-70. Epub 2006 Jul 24.

PMID:
16864853
[PubMed - indexed for MEDLINE]
Free Article
20.

Treatment outcome of adult patients with Burkitt lymphoma: results using the LMB protocol in Korea.

Choi MK, Jun HJ, Lee SY, Kim KH, Lim do H, Kim K, Ko YH, Kim WS, Kim SJ.

Ann Hematol. 2009 Nov;88(11):1099-106. doi: 10.1007/s00277-009-0729-3. Epub 2009 Mar 14.

PMID:
19288103
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk